Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic LeukemiaAnthony R. Mato, Wojciech Jurczak, Shuo Ma et al.|New England Journal of Medicine|2023Cited by 213
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016Steven M. Horwitz, Pierluigi Porcu, Andrew D. Zelenetz et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 141
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell LymphomaMichael Wang, Nirav N. Shah, Wojciech Jurczak et al.|Journal of Clinical Oncology|2023Cited by 106
Diffuse Large B-Cell Lymphoma Version 1.2016Andrew D. Zelenetz, Hema Sundar, Leo I. Gordon et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 87
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022William G. Wierda, Hema Sundar, Jennifer R. Brown et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 84